World1 outlet
FDA panel loosens restrictions for controversial peptides
The FDA panel has voted to ease restrictions on controversial peptides that have gained popularity online, despite limited human safety data. The decision represents a significant win for Health Secretary Robert F. Kennedy, who has been a vocal supporter of these largely understudied compounds.
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
How does this lean?
Comments
0No comments yet. Say what you noticed in the coverage.
Trending